Promo !

Retatrutide / Cagrilintide 10 mg + 5 mg0

Le prix initial était : $199.00.Le prix actuel est : $195.00.

Retatrutide / Cagrilintide 10 mg + 5 mg research-grade lyophilized powder supplied in a sealed glass vial. This dual-compound formulation is studied in experimental models of metabolic regulation, appetite signaling and energy balance via incretin and amylin-related pathways.

Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.

Retatrutide / Cagrilintide

Purity
High-purity research grade

 

Form
Lyophilized powder

 

Content
Retatrutide 10 mg + Cagrilintide 5 mg (15 mg total) per vial

 

Total content
15 mg combined lyophilized peptide

 

Packaging
Sealed glass vial with sterile stopper

 

Storage
Store lyophilized at 2–8 °C (desiccated, protect from light)

 

Molecular formula
Retatrutide C221H342N46O68; Cagrilintide C194H312N54O59S2

 

Molecular weight
Retatrutide ≈ 4731.4 g·mol⁻¹; Cagrilintide ≈ 4409 g·mol⁻¹

 

CAS number
Retatrutide: 2381089-83-2
Cagrilintide: 1415456-99-3

Research Overview

Retatrutide and cagrilintide are synthetic peptide analogues studied in advanced metabolic research. Retatrutide is investigated for its multi-receptor activity within incretin pathways, while cagrilintide is explored as a long-acting amylin analogue. In experimental settings, this combination is used to study appetite regulation, energy expenditure, glucose handling and metabolic signaling integration.

Primary Research Areas

  • Incretin & amylin signaling pathways: used to investigate combined modulation of GLP-1, GIP, glucagon and amylin-related receptor systems in metabolic research models.
  • Energy balance & appetite regulation: applied in experimental studies examining food intake behavior, satiety signaling and central–peripheral metabolic communication.
  • Glucose metabolism & insulin dynamics: explored in preclinical models assessing glycemic control, insulin sensitivity and pancreatic signaling responses.
  • Body-weight regulation models: studied in animal models of obesity and metabolic dysfunction to evaluate synergistic effects on adiposity and energy expenditure.
  • Neuroendocrine & metabolic integration: investigated for interactions between central appetite circuits, peripheral hormone signaling and adaptive metabolic responses.
Retatrutide and Cagrilintide are investigational peptide-based medications studied primarily for chronic weight management, obesity, and metabolic health. They belong to a new generation of multi-receptor therapeutics targeting hormonal pathways that regulate appetite, blood sugar, and energy expenditure. [1, 2, 3, 4, 5]

What is Retatrutide?

  • Mechanism (“Triple G” Agonist): Retatrutide (developed by Eli Lilly) is a single molecule that simultaneously activates three distinct hormone receptors:
    • GLP-1 (Glucagon-Like Peptide-1): Reduces appetite, slows stomach emptying, and increases insulin secretion.
    • GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances nutrient metabolism and insulin sensitivity.
    • Glucagon: Stimulates fat breakdown (lipolysis) and increases energy expenditure (calorie burning). [1, 2, 3]

  • Administration: Given as a once-weekly subcutaneous (under the skin) injection. [1, 2]

  • Clinical Status: Currently in advanced clinical trials (such as Phase 3 TRIUMPH studies) showing significant body weight reductions and improvements in liver fat and metabolic markers, though it is not yet commercially approved. [1, 2, 3]

What is Cagrilintide?

  • Mechanism (Amylin Analog): Cagrilintide (developed by Novo Nordisk) is a long-acting synthetic analog of amylin, a natural hormone released by the pancreas alongside insulin after meals. It targets amylin and calcitonin receptors to signal fullness, suppress appetite, and delay gastric emptying. [1, 2, 3]

  • Administration: Designed as a once-weekly subcutaneous injection. [1]

  • Clinical Status: Studied as a monotherapy, paired with semaglutide (known as CagriSema), or researched in combination studies alongside retatrutide to evaluate multi-receptor synergy. It is currently investigational and under regulatory review. [1, 2, 3]

Reconstitution

Recommended solvent — Bacteriostatic water

Bacteriostatic Water – 10 ml in glass vial - Limitless BioChem

For diluting lyophilized peptide powders, use a sterile and suitable research solvent such as bacteriostatic water (BAC), which may help support handling stability and reduce contamination risk.

For convenient laboratory use, see Bacteriostatic Water – 10 ml.

Why Limitless Biochem Shop?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.

Avis

Il n’y a pas encore d’avis.

Soyez le premier à laisser votre avis sur “Retatrutide / Cagrilintide 10 mg + 5 mg0”

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Panier

Save to list